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Abstract 
Purpose: There is an ongoing discussion how to assess acute mountain sickness (AMS) in real life conditions. Next 
to more-item scales with a cut off like the Lake Louise Self-Report (LLS), some authors suggested to use visual analog 
scales (VAS) to assess AMS. This study tried to contribute to this question using VAS items used for the Subjective Rat-
ings of Drug Effects, including an additional single item for AMS. Furthermore, we investigated if instruments devel-
oped to assess psychological well-being might predict AMS assessed via LLS or VAS.
Methods: 32 (19 Female) adult persons with known AMS susceptibility filled in questionnaires (Feeling Scale, Felt 
Arousal Scale, Activation Deactivation Check List, LLS, VAS) at a height of 3650 m above sea level.
Results: Correlation and regression analysis suggest a moderate to high relationship between the LLS score and the 
VAS items, including one VAS item asking for the severity of AMS, as well as psychological well-being.
Conclusion: In conclusion, using VAS items to assess AMS can be a more precise alternative to questionnaires like 
LLS, for people knowledgeable with AMS. Furthermore, researchers should be aware that psychological well-being 
might be an important parameter influencing the assessment of AMS.
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Background
Acute mountain sickness (AMS) is common after rapid 
ascent to altitudes greater than 2500  m. Characteristic 
symptoms of AMS include headache, fatigue, insomnia, 
loss of appetite, nausea and vomiting (Maggiorini et  al. 
1990). There are currently no diagnostic markers or reli-
able physiological parameters to assess AMS (Hext et al. 
2011). Therefore, the diagnosis of AMS depends on the 
self-rated assessment of symptoms’ intensity by the indi-
vidual person (Kayser et  al. 2010). One exception is the 
Hackett score which includes a structural interview and 
a physical examination (Hackett et  al. 1976). Neverthe-
less, self-evaluation through questionnaires is the main 
way for AMS assessment (Hext et al. 2011) and the Lake 
Louise Self-Report (LLS) (Roach et  al. 1993) is despite 
some critique the most popular questionnaire in use. It 
consists of 5 questions to be answered on a 4-point Likert 
scale and therefore requires little time to complete. Nev-
ertheless, there are difficulties in the assessment of the 
LLS which refer to the interpretation of the terminology 
used (Dellasanta et  al. 2007). Symptoms like headache 
and fatigue, as covered in the scale, may not consistently 
be caused by high altitude and their ratings are strongly 
dependent from the person asked and therefore influ-
enced by psychological aspects. Above that, McInnis 
et  al. (2013) revealed that sleep quality is not strongly 
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related to other symptoms of AMS and therefore might 
be discussed as an implied symptom of AMS. In addition 
to sleep, there is an ongoing discussion about the obliga-
tory presence of headache in the LLS. While Roach et al. 
(2011) underline the importance of headache as the main 
criterion for the diagnosis of AMS, West would rather 
include another assessment tool where also subjects 
without headache can be diagnosed with AMS (West 
2011).
A different and more comprehensive way of diagnosing 
AMS, which might reduce difficulties in the interpreta-
tion of the wording (Roach and Kayser 2007), is the Visual 
Analog Scale (VAS). The VAS is known from clinical stud-
ies for measuring, among others, changes in the intensity 
of symptoms such as headache (Lines et al. 2001) or nau-
sea (Hendey et  al. 2005). This method uses few descrip-
tive words and generally consists of a continuous 100 mm 
scale, reaching from the non-occurrence (left side) to the 
highest intensity of possible symptoms (right side). Par-
ticipants are free to choose any point on this scale on the 
basis of their subjective sensation of symptoms. Wagner 
et al. (2007) assessed in their study AMS using VAS. They 
showed the VAS to have a high reliability, presenting sig-
nificant correlations with the LLS. More recently, strong 
correlations between the LLS and VAS have been demon-
strated (Hext et al. 2011; Kayser et al. 2010; Slingo et al. 
2012; Wagner et al. 2012; van Roo et al. 2011). However 
inconsistencies in the diagnostic of AMS between those 
scales have been shown (Kayser et al. 2010) and no proven 
diagnostic cut off for AMS developed around the remark 
of LLS ≥  5, has been established (Hext et  al. 2011). The 
observed correlations were weaker when the LLS scored 
less than 5 (Hext et al. 2011; Kayser et al. 2010). Roach and 
Kayser (2007) suggested to extend the findings of Wag-
ner et  al. (2007) to different settings and languages. It is 
known, that hypoxia induces changes in mood states. At 
a height of 4300 m people became less friendly, less clear 
thinking, sleepier and dizzier but nevertheless happier 
(Shukitt-Hale et  al. 1991). How the psychological well-
being is related to AMS has not been evaluated yet. The 
following study included scales suggested for assessing 
psychological well-being during exercise (Ekkekakis et al. 
2004) like the Feeling Scale (FS) (Hardy and Rejeski 1989), 
the Felt Arousal Scale (FAS) (Sevebak and Murgatroyd 
1984) and the Activation-Deactivation Adjective Check 
List (ADACL) (Thayer 1978).
Therefore, this study aimed at answering the following 
questions: (1) Is there a correlation between the LLS and 
VAS measurement within a collective of subjects with an 
AMS history, during high-altitude exposure? (2) Is there 
a correlation between questionnaires for psychological 




After ethical approval from the institutional review 
board according to the guidelines of Helsinki, study 
participants were recruited by public advertisements. 
Subjects signed an informed consent form prior to the 
study. Thirty two healthy persons, 19 women and 13 men 
(38.8  ±  11.8  years, min: 20  years, max: 59  years; BMI 
22.7  ±  2.5  kg/m2) volunteered for the study. At least 2 
previous high-altitude exposures ≥3000 m within the last 
2 years and known AMS susceptibility were inclusion cri-
teria. 88 % of the volunteers live at a height between 500 
and 700 m and 12 % between 700 and 1040 m.
The high-altitude exposure took place at the Mönch-
sjochhut (Jungfrau-Aletsch, Switzerland) at 3650  m for 
the duration of 45 h. 50 % of the subjects had a placebo 
and 50  % an intermittent acclimatization process in the 
test chamber of the university. None of the subjects knew 
if they were intervention or control group. For the high-
altitude exposure, the subjects were driven to the bottom 
of the Jungfraujoch (Switzerland) at an altitude of 570 m 
where they spent their first night. The next morning they 
took the railway which carried them within 50  min to 
a height of 3454. The last 200  m were climbed on foot 
within 1  h. The volunteers slept in shared rooms and 
filled in the questionnaires described below during the 
afternoon of the second day.
Measures
Affective valence was assessed by the Feeling Scale (FS) 
(Hardy and Rejeski 1989). This single-item rating scale 
ranges from +5 to −5, with anchors at zero (‘‘neutral’’) 
and at all odd integers, ranging from ‘‘very good’’ (+5) 
to ‘‘very bad’’ (−5). Subjects were asked to estimate their 
actual well-being by marking one number on the Scale. 
Convergent validity information for the FS has been pro-
vided (Hardy and Rejeski 1989; van Landuyt et al. 2000).
Perceived activation was assessed by the Felt Arousal 
Scale (FAS) (Sevebak and Murgatroyd 1984). This single-
item rating scale ranges from 1 (‘‘low arousal’’) to 6 (‘‘high 
arousal’’). Volunteers were asked to note one number on 
the scale according to their actual arousal state. Arousal 
was explained through examples of high arousal states 
(anger, excitement, fear) or low arousal states (relaxation, 
boredom, calmness). The FAS has been used in previous 
physical activity studies, demonstrating convergent valid-
ity with other measures of perceived activation (van Lan-
duyt et al. 2000).
The Activation Deactivation Adjective Check List 
(ADACL) (Thayer 1978) is a 20-item measure of two 
bipolar dimensions, namely Energetic Arousal (EA) and 
Tense Arousal (TA). EA extends from Energy (e.g., ener-
getic, lively) to Tiredness (e.g., tired, drowsy), and TA 
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extends from Tension (e.g., tense, jittery) to Calmness 
(e.g., calm, at rest). The ADACL was administered with 
its standard instructions and its 4-point response scale, 
which ranges from ‘‘definitely feel’’ to ‘‘definitely do not 
feel’’. Evidence for the reliability and structural validity of 
the ADACL has been provided (Thayer 1978). In previ-
ous research in the context of physical activity, the scales 
of the ADACL have shown satisfactory internal consist-
ency, with values of Cronbach’s alpha coefficients ranging 
from .70 to .96 (Ekkekakis et al. 2005).
The VAS used in this study was developed for the pur-
pose of subjective ratings of drug effects and called the 
Line Analogue Rating Scales for Sedation (LARS) (Hind-
march and Gudgeon 1980). In previous studies (Gudg-
eon and Hindmarch 1983; Subhan and Hindmarch 1985), 
100  mm line analogue rating scales were used to assess 
perceived drug effects, whereas the mean score of the 
assessments was used as an index of subjective mood 
and sedation. In this study, the VAS included along the 
LARS items fatigue, drowsiness, dizziness, alertness and 
energetic, also the items relaxation and acute mountain 
sickness, which were rated on a 100  mm analogue line. 
Thereby the left side covered the non-occurrence of symp-
toms known in AMS (e.g. “not tired” or “not dizzy”), or 
the occurrence of symptoms oppositional to those known 
in AMS (e.g. “extremely awake”, “energetic”). The right 
side covered their most severe expansion (e.g. “extremely 
tired”, “extremely dizzy” or “not awake”, “extremely unen-
ergetic”). The total VAS score is the mean of all accumu-
lated items used by the VAS questionnaire.
The LLS (Roach et al. 1993) is filled in on a 4-point Lik-
ert scale (0–3) and consists of the five items headache, 
gastrointestinal symptoms, fatigue and weakness, diz-
ziness and lightheadedness, and difficulty sleeping. For 
the diagnosis of AMS, headache is an obligatory crite-
rion with at least one other symptom of the LLS and a 
total score of ≥3 (Roach et  al. 1993). In line with other 
research a more valid cut-off score in presence of head-
ache is 5 (Kayser et al. 2010; Dellasanta et al. 2007; Wag-
ner et al. 2012).
Data analyses
Mann–Whitney U test was used to calculate group dif-
ferences. A correlation test by Spearman was applied to 
calculate correlations between ADACL, VAS and LLS. 
The statistical program used was SPSS (version 21.0; 
SPSS Inc., Chicago, USA, 2013). The significance level 
was set at p < .05.
Results
All 32 subjects filled in the questionnaires; however, two 
subjects did not complete the ADACL and were therefore 
excluded from all analyses concerning the ADACL.
The subjects were divided into an AMS (LLS ≥ 5) and a 
non AMS group (LLS < 5). Mann–Whitney U test calcu-
lations showed a significant difference in the VAS items 
fatigue, drowsiness, alertness and AMS. ADACL, FS 
and FAS showed no significant differences between the 
groups (Table 1).
The comparisons between the scores at the different 
VAS and the LLS score revealed highly significant cor-
relations (p  <  .001) for six out of seven items (Table  2). 
The items fatigue, alertness, drowsiness, AMS, energy 
and the total VAS score showed moderate to strong cor-
relations. Only the item relaxation resulted in a weak cor-
relation with the LLS Score. The item dizziness did not 
correlate with the LLS score, but instead with the single 
LLS item dizziness (r = .378, p = .033). Despite the high 
correlation between the VAS-item acute mountain sick-
ness (AMS) and the LLS score (r =  .563, p =  .001), no 
linear correlation was shown (Fig. 1). 50 % of the subjects 
had a score ≥5 of AMS in LLS. However a significant 
correlation between the VAS-item AMS and the LLS 
score was shown for the 50 % of the subjects who scored 
below 5 (r = .647, p = .007), and for those diagnosed with 
AMS by the LLS score (≥5) (r = .553, p = .026). The LLS, 
being predicted from the VAS (LLS ≥ 5; y = 2.789 + .517 
*x), revealed a cut-off point of 4.2 cm for the VAS item 
AMS. Four people diagnosed as not mountain sick by 
the LLS, listed themselves above the VAS AMS cut-off 
point. Reversely, eight people who were diagnosed with 
AMS on behalf of the LLS, stated themselves as not acute 
mountain sick. 21 people were diagnosed consistently by 
both scales (8 people with AMS and 13 people without 
AMS) (Fig. 1). 
The ADACL subscale score EA correlated negatively 
with the LLS score (r = −.536, p < .001) (Table 3; Fig. 2), 
as well as with the total VAS score (r = −.936, p < .001). 
On the other hand, no correlation could be shown 
between the ADACL subscale TA and the LLS as well 
as the FS (r = −.328, p =  .068). A negative correlation 
was found for the FS and the VAS-item AMS (r = −.535, 
p =  .002), the total VAS score (r = −.610, p < .001) and 
the ADACL subscale EA (r =  .683, p <  .001). In people 
diagnosed with AMS (LLS ≥  5), FS showed only a sig-
nificant negative correlation with the VAS item energy 
(r = −.645, p =  .007). The FAS showed no relationship 
to any scores despite the ADACL subscale tension state 
(r = .461, p = .010).
Discussion
In line with other research (Hext et  al. 2011; Kayser 
et  al. 2010; Dellasanta et  al. 2007; Wagner et  al. 2007, 
2012), the present study showed correlations between 
the items of the VAS and the LLS score. In previous 
research no comparisons were made between single 
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VAS-items asking about AMS symptoms and the total 
LLS score (Hext et al. 2011; Wagner et al. 2007, 2012). 
Only Kayser et  al. (2010) plotted the VAS-item head-
ache versus the LLS-item headache, and the data points 
did not conform to the line of identity. The VAS item 
headache was not included in the present study, never-
theless moderate to strong correlations between the sin-
gle VAS-items and the total LLS score were found for 6 
out of 7 items. Only the item dizziness was not related 
to the LLS score, but to the LLS item dizziness. Out of 
sixteen people who had a LLS Score of 5 or above, only 
six reported moderate dizziness. Further, the VAS Score 
dizziness showed no significant difference between 
those diagnosed with AMS (LLS  ≥  5) and those who 
had a LLS Score below 5. This raises the question if diz-
ziness is a necessary item in assessing AMS. All sub-
jects reporting dizziness and lightheadedness had an 
LLS Score above 7. Thus the item did not contribute 
to the cut-off of a LLS-score of 5. Out of 7 items of the 
VAS-score, 4 showed a significant difference between 
the AMS groups. Those were namely fatigue, alert-
ness, drowsiness and AMS. People who were assessed 
as acute mountain sick by the LLS defined themselves 
significantly different with AMS on the VAS scale 
(Table 1).
The linear scaling characteristics of the VAS item AMS 
and the LLS score (Fig.  1) do not plot close to a theo-
retical identity line. Kayser et al. (2010) revealed in their 
study a threshold effect for the LLS scores below 5–6 
leading to low VAS scores. The present study does not 
reflect this result. Nevertheless only 64 % of the subjects 
were consistently diagnosed with AMS by both scales. 
Due to the VAS-AMS-scale, four subjects who would not 
have been diagnosed with AMS by the LLS (score  <  5) 
described themselves as moderately to almost severely 
Table 1 Mean, standard deviations and  group differences 
between subjects diagnosed with and without AMS by the 
LSS
The VAS values are given in cm. Data are shown as Mean ± standard deviation 
for all subjects divided into AMS and non AMS group
LLS Lake Louise Self-Report, ADACL Activation Deactivation Check List, VAS Visual 
Analogue Scale, AMS Acute Mountain Sickness
Significance level: * p < .05; ** p < .01
Questionnaire Item Mean p
No AMS AMS
(LLS < 5) (LLS ≥ 5)




0.06 (±0.25) 1.31 (±0.87) <.001**
Fatigue and 
weakness




0.00 (±0.00) 0.94 (±0.93) .006**
Difficulty 
sleeping
0.63 (±.81) 1.63 (±1.20) .021*
Total score 1.25 (±1.24) 7.63 (±1.63) <.001**
ADACL Tense arousal 13.75 (±3.04) 16.00 (±6.00) .448
Energetic 
activation
29.63 (±7.81) 25.43 (±8.78) .093
Feeling scale 3.31 (±1.78) 2.69 (±1.78) .305
Felt arousal 
scale
2.06 (±1.06) 2.50 (±.97) .224
VAS Fatigue 2.50 (±2.13) 4.88 (±2.42) .004**
Relaxation 1.69 (±2.44) 2.38 (±2.00) .184
Drowsiness 2.31 (±2.09) 5.25 (±2.21) .001**
Alertness 2.75 (±2.14) 4.94 (±2.11) .008**
Dizziness .38 (±.72) 1.19 (±1.97) .445
Energy 2.69 (±2.73) 4.38 (±2.68) .061
AMS 2.19 (±3.49) 4.19 (±2.97) .039*
Table 2 Relationship between the LLS score, the single LLS items and the single VAS-items
Data are shown as spearman correlation coefficients at one time point at 3650 m (n = 32)
VAS Visual Analogue Scale, VAS AMS Visual Analogue Score Acute Mountain Sickness, LLS Lake Louise Self-Report
Significance level: * p < .05; ** p < .01
VAS fatigue VAS relaxation VAS drowsiness VAS alertness VAS dizziness VAS energy VAS AMS VAS total
LLS
Total score .661** .365* .700** .595** .195 .525** .563** .633**
Headache .454** .184 .488** .396* .087 .275 .424* .389*
Gastrointestinal symptoms .590** .360* .604** .598** .291 .352* .492** .563**
Fatigue and weakness .470** .362* .532** .329 .078 .537** .414* .498**
Dizziness and lightheaded-
ness
.457** .174 .472** .387* .365* .320 .294 .410*
Difficulty sleeping .347 .193 .409* .434* −.026 .376* .336 .383*
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mountain sick. Eight people who would have been diag-
nosed as sick by the LLS (score ≥ 5) were below the cut 
off line of the VAS. In regard to previous literature (Hext 
et  al. 2011; Wagner et  al. 2007) and the results of the 
actual study, we think that a single VAS-item to assess 
overall AMS intensity can help to immediately assess the 
changes in the sensation of AMS but might only be effec-
tive for experienced mountaineers. However, moderate 
to strong correlations between the VAS and the LLS have 
been shown. Therefore, to answer our first research ques-
tion, we found a strong relationship between the VAS 
measurement and the LLS. Despite the huge reputation 
of the LLS, in our opinion a VAS system might give fur-
ther possibilities to work out a more valid cut off-score 
in comparison to an instrument with a 4-point Likert 
approach as the LLS, in the future.
The second research question involves a possible rela-
tionship between psychological well-being and AMS. 
Due to the strong relation between the VAS items relaxa-
tion, drowsiness, alertness, energy and the ADACL sub-
scale EA with the LLS (Fig.  2), AMS might be related 
to a greater complex of physiological and psychologi-
cal well-being. Moreover, a significant difference in the 
ADACL subscale EA was calculated for people diag-
nosed with AMS (LLS ≥ 3). People suffering from AMS 
felt less energetic than healthy subjects. The subscale 
EA covers items including fatigue and alertness. These 
items were also part of the VAS and thus showed a strong 
relationship in direct comparison. Despite this relation-
ship, ADACL might not be a good tool for measuring 
AMS because it takes a long time to fill in the 20 items 
of this instrument and furthermore, subscales have to be 
calculated afterwards. A shorter way of assessing sub-
jective mood is the FS. It showed a moderate negative 
effect (r = −.536) for the VAS-item AMS and every other 
item of the VAS, but no correlation to the LLS score, or 
any items of the LLS. One might assume that subjective 
well-being diminishes when people suffer from AMS. 






















Fig. 1 LLS, Lake Louise Self-Report; VAS, Visual Analogue Scale; AMS, acute mountain sickness. Relationship between the LLS score and the single 
VAS-item AMS. Regression calculations revealed a cut off line for VAS at 4.2 cm for people diagnosed with AMS (LLS ≥ 5). Black dots illustrate multi-
ple persons. 6 persons had a LLS and VAS score of 0. Both other dots mark two persons
Table 3 Relationship between  the LLS score and  the 
ADACL subscales, FS and FAS
Data are shown as spearman correlation coefficients at one time point at 
3650 m. N = 32 for FS and FAS, n = 30 for ADACL EA and TA
LLS Lake Louise Self-Report, ADACL [EA] Activation Deactivation Check List 
Energetic Activation, ADACL [TA] Activation Deactivation Check List Tense 
Arousal; FS, Feelings Scale, FAS Felt Arousal Scale
Significance level: * p < .05; ** p < .01
ADACL [EA] ADACL [TA] FS FAS
LLS score −.536** .190 −.347 .202
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happiness improved at a height of 4300  m even though 
the people became less friendly, less clear thinking, sleep-
ier and dizzier. If the LLS remains the most used ques-
tionnaire for assessing AMS, it could be concluded that 
the subjective well-being might not be a factor for meas-
uring AMS, but nevertheless could influence it. In people 
diagnosed with AMS (LLS ≥ 5) the subjective well-being 
is negatively correlated with energy but not with AMS. In 
climbers who started to experience either fatigue or AMS 
at a height of 5640, subjective vitality and intrinsic moti-
vation scores dropped (Norling et  al. 2014). Therefore, 
research in this field might contribute to more knowledge 
of potential interactions between psychological states 
and AMS. Furthermore research has to examine how a 
reduced psychological well-being might be a predictor or 
an early warning for AMS.
Limitations include slightly different weather condi-
tions between the measurements in October and May. 
This could be a factor which may have affected psycho-
logical well-being of participants. Due to the non-exist-
ence in the LARS (Gudgeon and Hindmarch 1983), the 
present study did not contain the VAS-item headache, 
which might be discussed as a limitation of this approach. 
Furthermore, some of the subjects were already accus-
tomed to the questionnaires because of former high alti-
tude study participation in a laboratory situation. As a 
methodical limitation of this study it should be discussed 
that AMS was defined with an LLS ≥  5. The discussed 
results of the VAS are therefore linked to the LLS. Fur-
thermore, no tests for sensitivity and specificity as well 
as no decision plots for the determination of optimum 
values of VAS for the diagnosis of AMS as it was done 
by Slingo et al. (2012), have been performed in this study 
due to a low number of repeated measurements.
In conclusion, this study showed moderate to strong 
correlations between the VAS-items and the LLS. Using 
the single VAS-item AMS can be a helpful alternative 
to questionnaires like the LLS. Changes in AMS might 
be detected more specifically and thus the decision on 
the descent of a person with AMS could be taken more 
accurately. A reduced subjective well-being resulted in 
reduced energy and vice versa in people diagnosed with 
AMS. Correlations between AMS and subjective well-
being could not been shown in this study. Future studies 
should try to assess physiological as well as psychological 
predictors of AMS and compare it to the VAS item AMS 
and the LLS.
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